Decentralized Clinical Trials (DCT) Draft Guidance - 06/20/2023

[FDA]

As part of the FDA’s efforts to be responsive to the rapidly evolving clinical trial landscape and clarify the Agency’s recommendations on the conduct of DCTs, the FDA will provide an overview of the draft guidance titled Decentralized Clinical Trials for Drugs, Biological Products, and Devices.


Baca selengkapnya di : http://www.fda.gov...